-
PROVIDERS
Watch now
Are you getting the full picture? A webinar series on the power of comprehensive intelligent diagnostics
-
LIFE SCIENCES
ENROLL NOW
Tempus’ Patient-Derived Organoid ScreensEvaluate the efficacy of your preclinical compounds using fixed organoid panels designed for diverse therapeutic applications.Space is limited — enroll by June 30, 2025, to secure your spot.
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
-
ABOUT US
View Job Postings
We’re looking for people who can change the world.
- INVESTORS
Original Webinar Date:
05/31/2025
Industry Expert Theater Presentation* from the 2025 ASCO® Annual Meeting
Powering Today’s Insights for a Smarter Tomorrow: Intelligent Diagnostics and AI Solutions Across the Cancer Continuum
Speakers
Ezra Cohen, MD, FASCO
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
Chief Medical Officer of Oncology, Tempus
Kate Sasser, PhD
Chief Scientific Officer, Tempus
Halla Nimeiri, MD
Chief Development Officer, Tempus
In this recording, hear from Drs. Ezra Cohen, Kate Sasser and Halla Nimeiri from Tempus as they discuss how cutting-edge AI-enabled technologies are embedded across Tempus’ platform to enhance insights, streamline care and drive innovation. Learn how real-world data and an expanding comprehensive portfolio – including MRD and monitoring assays – are helping redefine precision oncology.
-
06/25/2024Revolutionizing Cardiac Care: AI-driven detection and treatment of critical heart valve disease at Boulder Community Health
Discover how Tempus Next's AI-powered care pathway platform transformed patient outcomes by helping ensure timely, guideline-directed treatment for critical heart valve disease at Boulder Community Health
Read more -
04/15/2024Identifying patients with Valvular Heart Disease: A partnership between St.Francis and Tempus
Learn how the deployment of Tempus Next, an AI-enabled clinical care pathway solution at St. Francis enabled guideline directed care for patients with structural heart disease.
Read more -
04/15/2024Closing the biomarker testing gap for early stage NSCLC patients with Tempus Next
Learn how Tempus Next was deployed at TriHealth Cancer and Blood Institute in Cincinnati, Ohio to surface and close gaps in biomarker testing for NSCLC patients.
Read more